Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ELVN - Enliven Therapeutics, Inc.
-148 M
LAST VALUE
-2687.52%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR